Cellular Therapy for Solid Tumors

The SITC Spring Scientific, Cellular Therapy for Solid Tumors, will address the recent advances in adoptive cellular therapy for solid tumors and rate-limiting challenges that impede bringing these novel therapies to patients in need. The program will feature in-depth discussions of the latest scientific insights and advances in the field and unique opportunities and unanswered questions in the areas of target antigen selection, product design, and therapeutic efficacy and safety.

SITC will bring the brightest minds and the next generation of leaders together to explore the more promising science and develop novel opportunities to address these challenges.

Target Audience

The target audience for this program includes clinical, basic, and translational researchers from academic, industry, or government settings interested in exploring differences between hematologic malignancies and solid tumors, synthetic versus endogenous immunity, and in vivo cell therapy with a focus on emerging platform technologies.

Learning Objectives

1. Describe types of cellular therapies currently being explored for the treatment of solid tumors and their mechanisms of action
2. Outline methods to identify therapeutic targets and design/develop cellular therapies for solid tumors, with an emphasis on improving therapeutic efficacy
3. Analyze current clinical and translational studies of engineered and non-engineered cellular therapies for solid tumors

Registration Information

Registration will open in early august.

Abstracts

Spring Scientific Abstract Awards 

Five abstract awards will be offered for outstanding abstract submissions. The awardees will be selected by the program organizers from the top scored abstracts. Those selected will receive complimentary registration to the Spring Scientific, as well as a certificate and a poster ribbon.

Two of the five awards will be reserved for those who self-identify as individuals from underrepresented racial and ethnic groups in the biomedical sciences according to the NIH definition. The information collected in response to the self-identifying process will only be viewed by SITC staff and program organizers.

Questions?

If you have questions about this program, please contact education@sitcancer.org.